CVS Health has a new leader at the helm. The health care giant announced that CEO Karen Lynch is stepping down, with shares plummeting 19% this year. The company expects earnings to fall below Wall Street predictions, struggling with rising insurance costs and sluggish drugstore sales. David Joyner, a long-time CVS executive, will take over, facing challenges like increasing competition online and investor pressure. Analysts note that the change in leadership comes after another quarter of poor performance, making it hard to argue against a shakeup. CVS Health has been cutting its financial expectations for the third time this year, mainly due to growing claims from Medicare Advantage coverage. The company runs a massive drugstore chain, insurance arm covering nearly 27 million people, and a large pharmacy benefit management business. A recent statement by Glenview Capital Management highlighted the company’s falling short in investment and actuarial strategies. Joyner’s extensive experience in health care and pharmacy benefit management positions him to tackle the industry’s challenges head-on. Chairman Roger Farah will now serve as executive chairman, supporting Joyner in this transition. With a preliminary forecast for third-quarter earnings significantly lower than expected due to rising medical costs, CVS Health aims to navigate through these hurdles.

New Captain at CVS Health's Helm: David Joyner Steps In

Actions